Low immunosuppressive burden after HLA-matched related or unrelated BMT using posttransplantation cyclophosphamide

The intensive and prolonged immunosuppressive therapy required to prevent or treat graft-versus-host disease (GVHD) after allogeneic blood or marrow transplantation (alloBMT) puts patients at substantial risk for life-threatening infections, organ toxicity, and disease relapse. Posttransplantation c...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Blood
Main Authors: Kanakry, Christopher G., Bolaños-Meade, Javier, Kasamon, Yvette L., Zahurak, Marianna, Durakovic, Nadira, Furlong, Terry, Mielcarek, Marco, Medeot, Marta, Gojo, Ivana, Smith, B. Douglas, Kanakry, Jennifer A., Borrello, Ivan M., Brodsky, Robert A., Gladstone, Douglas E., Huff, Carol Ann, Matsui, William H., Swinnen, Lode J., Cooke, Kenneth R., Ambinder, Richard F., Fuchs, Ephraim J., de Lima, Marcos J., Andersson, Borje S., Varadhan, Ravi, O’Donnell, Paul V., Jones, Richard J., Luznik, Leo
Formato: Artigo
Idioma:Inglês
Publicado em: American Society of Hematology 2017
Assuntos:
Transplantation
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5345732/
https://ncbi.nlm.nih.gov/pubmed/28049637
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/blood-2016-09-737825
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados